Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma.
Neuroendocrine (NE) differentiation has gained increased attention as a prostate cancer (PC) prognostic marker. The aim of this study is to determine whether host germline genetic variation influences tumor progression and metastasis in C57BL/6-Tg(TRAMP)8247Ng/J (TRAMP) mouse model of aggressive NEP...
Guardado en:
Autores principales: | Shashank J Patel, Alfredo A Molinolo, Silvio Gutkind, Nigel P S Crawford |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/98df94023eb24663a41da0fd4f7b9870 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Imaging of Neuroendocrine Prostatic Carcinoma
por: Ahmed Taher, et al.
Publicado: (2021) -
Sympathetic signaling facilitates progression of neuroendocrine prostate cancer
por: Shubham Dwivedi, et al.
Publicado: (2021) -
Development and comparison of novel bioluminescent mouse models of pancreatic neuroendocrine neoplasm metastasis
por: Courtney A. Kaemmer, et al.
Publicado: (2021) -
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
por: Yota Yasumizu, et al.
Publicado: (2020) -
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
por: Marco Matejcic, et al.
Publicado: (2018)